drugset / Trial / NCT00824616
A Study to Test MK-0941 in Adults With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0941-018)
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to test the effect MK-0941 as add-on therapy for adults taking insulin for Type 2 Diabetes.
Timeline
- Start
- 2009-01
- Primary completion
- 2010-05
- Completion
- 2010-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MK-0941 | Small molecule | 5 mg | — |
| Subject | MK-0941 | Small molecule | 10 mg | — |
| Background | insulin glargine | Protein / enzyme biologic | — | Subcutaneous |